← Eichor
Condition: Liver And Intrahepatic Biliary Tract Cancer Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Liver And Intrahepatic Biliary Tract Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese
Phase N/A · 1 location(s) · Ruijin Hospital · NCT05870969Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment
NA · 1 location(s) · Shanghai Zhongshan Hospital · NCT06794073EGCG for Hepatocellular Carcinoma Chemoprevention
Phase 2 · 1 location(s) · University of Texas Southwestern Medical Center · NCT06015022A Clinical Study on the Safety, Tolerability and Efficacy of Neoantigen-based Personalized mRNA Therapy iNeo-Vac-R01 Plu
Phase 1/Phase 2 · 1 location(s) · Yinghua Xu · NCT07495215Stereotactic Radiosurgery Versus Radiofrequency Ablation for Primary Liver Cancer
Phase 2 · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT06766643Microwave Ablation Simultaneously Combined With Lenavatinib for Recurrent Hepatocellular Carcinoma
NA · 1 location(s) · Sun Yat-sen University · NCT05444478HAIC Compared With TACE in Huge Hepatocellular Carcinoma
Phase N/A · 1 location(s) · Sun Yat-sen University · NCT06641713Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology
Phase N/A · 1 location(s) · Palo Alto Veterans Institute for Research · NCT07303725DEB-TACE Prior to Liver Transplantation in the Treatment of HCC
Phase 4 · 1 location(s) · RenJi Hospital · NCT06353126The AMARA (As Much As Reasonably Achievable) Study
Phase N/A · 1 location(s) · University Hospital of Patras · NCT06257030Prognostic Impact of Adjuvant Therapy in Primary Hepatic Sarcomatoid Carcinoma
Phase N/A · 1 location(s) · West China Hospital · NCT06950814Testing the Combination of the Anticancer Drug Durvalumab With Chemotherapy (Gemcitabine and Cisplatin) at Improving Out
Phase 2 · 58 location(s) · National Cancer Institute (NCI) · NCT06050252Selective Internal Radiation Therapy and Capecitabine (Chemotherapy) Treatment for Liver Cancer
Phase 2 · 7 location(s) · Center Eugene Marquis · NCT05265208At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
Phase 2 · 2 location(s) · Mayo Clinic · NCT05969860Liver Cancer and Immunotherapy in the Liquid Biopsy Era
NA · 1 location(s) · University Hospital, Montpellier · NCT05810402Intravital Microscopy in Human Solid Tumors
NA · 1 location(s) · Mayo Clinic · NCT03823144Exploring the Association of Imaging and Tumor Microenvironment in Liver Cancer Using Radiogenomic Approach（Radiogenomic
Phase N/A · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT06536998A Phase II/III Trial Comparing Transarterial Tirapazamine Embolization (TATE) With cTACE for Intermediate-stage Liver Ca
Phase 2/Phase 3 · 2 location(s) · Zhejiang Raygene Pharmaceuticals Co., Ltd · NCT06844357Study Assessing PET Imaging With Zirconium-labelled Girentuximab in Patients With HCC, BTC or NEN
NA · 2 location(s) · Nantes University Hospital · NCT06735560Large Language Models Assist in Tumor MDT
NA · 2 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT07504367The Impact of Emotional Stress on Immunotherapy Outcomes in Liver Cancer Patients: A Multi-Cohort Study
Phase N/A · 5 location(s) · Guilin Medical University, China · NCT07141056Distance-Based Exercise to Preserve Function and Prevent Disability
NA · 18 location(s) · Alliance for Clinical Trials in Oncology · NCT07059884Safety and Efficacy of Metabolically Armed Tumor-lnfiltrating Lymphocytes (Meta10-TIL) for the Treatment of Advanced Sol
EARLY_Phase 1 · 1 location(s) · Anhui Provincial Hospital · NCT07106814Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy
NA · 1 location(s) · Englewood Hospital and Medical Center · NCT06681818The Dragon PLC Trial (DRAGON-PLC)
NA · 55 location(s) · Maastricht University · NCT06914648Trop2-targeted immunoPET Imaging of Solid Tumors
Phase 2/Phase 3 · 1 location(s) · RenJi Hospital · NCT06851663National Liver Cancer Screening Trial
Phase 4 · 18 location(s) · University of Texas Southwestern Medical Center · NCT06084234Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis
Phase 3 · 32 location(s) · Can-Fite BioPharma · NCT05201404Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FLORA)
Phase 2 · 7 location(s) · Michael Dill · NCT05690048Prospective Clinical Database Construction for Liver Cancer Diagnosis and Treatment
Phase N/A · 1 location(s) · Tongji Hospital · NCT07587216
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.